-
2024-512358-78-00
7
2015-01-20
Solid Tumors
-
2024-516993-31-00
5
2026-05-11
Renal Cell Carcinoma
-
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
-
2024-519540-32-00
11
2026-05-06
post COVID
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2025-522187-32-01
6
2026-04-23
Lupus Nephritis
-
2024-520014-22-00
5
2026-04-22
Locally advanced/metastatic urothelial carcinoma
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2024-514874-36-01
4
2026-04-17
Refractory angina due to obstructive coronary artery disease
-
2024-516898-72-00
10
2026-04-17
Perihilar cholangiocarcinoma, distal cholangiocarcinoma
-
2025-523085-24-00
5
2026-04-13
Biliary Tract Cancer
-
2025-523515-11-00
1
2026-04-03
Early Alzheimer's Disease
-
2025-523781-25-00
1
2026-04-02
metastatic solid cancer, muscle invasive bladder cancer, localized or
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2025-521286-27-00
10
2026-03-26
Immune-mediated thrombocytopenia, Autoimmune thrombocytopenia, Autoimm
-
2025-522046-42-00
5
2026-03-24
Colonic disease
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2025-521036-11-00
5
2026-03-23
Immune system disseases
-
2024-518210-81-00
5
2026-03-18
Advanced Hepatocellular Carcinoma
-
2023-505556-21-00
5
2026-03-12
cocaine use disorder
-
2025-521117-88-00
5
2026-03-11
Cardiovascular Disease
-
2025-523692-39-00
5
2026-03-11
locally advanced rectal cancer
-
2025-521284-12-00
5
2026-03-05
Non-small cell lung cancer
-
2025-521035-37-00
5
2026-03-02
Immune system diseases